Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,077 | -5,751 | -16,777 | -10,309 | -5,813 |
| Depreciation Amortization | 1,051 | 530 | 2,085 | 1,547 | 1,064 |
| Accounts receivable | -316 | 109 | -432 | -133 | -30 |
| Accounts payable and accrued liabilities | 4,853 | 2,503 | 3,821 | 1,814 | 1,372 |
| Other Working Capital | 4,731 | 2,699 | 2,796 | 1,045 | 1,405 |
| Other Operating Activity | 3,436 | -4,453 | -1,260 | -256 | -956 |
| Operating Cash Flow | $-9,323 | $-4,363 | $-9,767 | $-6,292 | $-2,957 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -20 | N/A | N/A |
| PPE Investments | -416 | -222 | -355 | -252 | -149 |
| Other Investing Activity | 61 | 13 | 55 | 30 | 24 |
| Investing Cash Flow | $-355 | $-209 | $-321 | $-222 | $-125 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,808 | 8,918 | 8,901 | 9,153 | N/A |
| Other Financing Activity | -916 | -829 | -2 | -326 | -337 |
| Financing Cash Flow | $7,892 | $8,089 | $8,899 | $8,826 | $-337 |
| Exchange Rate Effect | 61 | 78 | -20 | -227 | -126 |
| Beginning Cash Position | 6,294 | 6,373 | 7,624 | 7,538 | 7,797 |
| End Cash Position | 4,569 | 9,967 | 6,416 | 9,623 | 4,252 |
| Net Cash Flow | $-1,725 | $3,594 | $-1,209 | $2,085 | $-3,545 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,323 | -4,363 | -9,767 | -6,292 | -2,957 |
| Capital Expenditure | -416 | -222 | -355 | -252 | -149 |
| Free Cash Flow | -9,739 | -4,586 | -10,122 | -6,545 | -3,106 |